Review
Open access
Aug 2026
Treatment of antibody-mediated rejection in heart transplantation: from empirical combination to multi-target precision intervention
The treatment paradigm is transitioning from empirical combination therapy to biomarker−driven, multi−target precision intervention covering the entire sequence of “production–circulation–effector pathways”, and the rationale underlying this evolution is delineated.
Ning Xu, Yaqin Dong, Yehong Yue et al.
· Frontiers in Immunology · 0 citations